NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report ...

A copy of the Appendix 4C – Quarterly Cash Flow Report for the fourth quarter FY2023 is available on the investor page of the company’s website www.mesoblast.com. About Mesoblast ...

Sydney, Australia--(Newsfile Corp. - April 29, 2025) - Established gold producer Austral Gold Limited's (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company) is pleased to announce that ...

Sydney, Australia--(Newsfile Corp. - January 29, 2025) - Established gold producer Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company) is pleased to announce that ...

--Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the third quarter ended March 31, 2025 ...

Established gold producer Austral Gold Limited's is pleased to announce that it has filed its Q3 2024 Quarterly Activity Report. Neither TSX Venture Exchange nor its Regulation Services Provider ...

Sydney, Australia--(Newsfile Corp. - January 30, 2024) - Established gold producer Austral Gold Limited (ASX: AGD) (TSXV: AGLD) (OTCQB: AGLDF) (Austral or the Company) is pleased to announce that ...